bpc 157 vs bpc 157 acetate (acetate) (GEPPPGKPADDAGLV, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, CAS Number: 1628202-19-6) BPC-157 acetate | CAS#216441-37-1 |

At nearly 5000 Da, it approaches the upper limit of what intranasal delivery can effectively handle

What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry

SeekPeptides has analyzed hundreds of compounded formulations, and the glycine question comes up more than almost any other

Combination safety profile No documented adverse interactions between BPC-157 and TB-500 emerge from available research or community experience

Some more severe, but rare, side effects that can occur are low potassium levels, muscle cramps, irregular heartbeat, chest pains, or blurred vision

This is to avoid serious health issues